By Abigail Townsend
Date: Tuesday 23 Mar 2021
(Sharecast News) - A cocktail of antibodies developed by Roche and Regeneron Pharmaceuticals to treat Covid-19 has been shown to cut hospitalisation or death by 70%, the Swiss drugmaker said on Tuesday.
By Alexander Bueso
Date: Tuesday 26 Jan 2021
(Sharecast News) - Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.
By Alexander Bueso
Date: Wednesday 30 Sep 2020
(Sharecast News) - Early trial results for Regeneron's monoclonal antibody cocktail showed that it helped to alleviate symptoms in patients in mild-to-moderate cases of Covid-19.
Currency | US Dollars |
Share Price | $ 598.16 |
Change Today | $ 7.15 |
% Change | 1.21 % |
52 Week High | $1,201.76 |
52 Week Low | $490.81 |
Volume | 1,010,305 |
Shares Issued | 107.80m |
Market Cap | $64,482m |
RiskGrade | 129 |
Strong Buy | 9 |
Buy | 11 |
Neutral | 5 |
Sell | 2 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
16:00 | 83,202 @ $598.16 |
16:00 | 100 @ $598.45 |
15:59 | 157 @ $598.05 |
15:59 | 100 @ $598.28 |
15:59 | 100 @ $598.08 |
You are here: research